Patents by Inventor Jimmy M. Fountoulakis

Jimmy M. Fountoulakis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5426038
    Abstract: A process for producing an antibiotic compound which is normally a minor component in the cultivation of Z. arboricola to be the major product is described.
    Type: Grant
    Filed: February 14, 1994
    Date of Patent: June 20, 1995
    Assignee: Merck & Co, Inc.
    Inventors: Jimmy M. Fountoulakis, Prakash S. Masurekar, Louis Kaplan
  • Patent number: 5162211
    Abstract: A new antibiotic cyclic lipopeptide and a method of producing it are described. The agent has very high activity against human pathogens and is of very low mammalian toxicity.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: November 10, 1992
    Assignee: Merck & Co., Inc.
    Inventors: David F. Sesin, Jimmy M. Fountoulakis, Prakash S. Masurekar, Louis Kaplan
  • Patent number: 5137813
    Abstract: A process for producing an antibiotic compound which is normally one of several minor components in the cultivation of Z. arboricola ATCC 20868 to be the primary product is described.
    Type: Grant
    Filed: June 18, 1990
    Date of Patent: August 11, 1992
    Assignee: Merck & Co., Inc.
    Inventors: Jimmy M. Fountoulakis, Prakash S. Masurekar
  • Patent number: 5049546
    Abstract: A new antibiotic cyclic lipopeptide and a method of producing it are described. The agent has very high activity against human pathogens and is of very low mammalian toxicity.
    Type: Grant
    Filed: March 19, 1990
    Date of Patent: September 17, 1991
    Assignee: Merck & Co., Inc.
    Inventors: David F. Sesin, Jerrold M. Liesch, Jimmy M. Fountoulakis, Prakash S. Masurekar, Louis Kaplan, Carol F. Wichmann
  • Patent number: 5021403
    Abstract: A new antibiotic cyclic lipopeptide and a method of producing it are described. The agent has very high activity against human pathogens and is of very low mammalian toxicity.
    Type: Grant
    Filed: March 19, 1990
    Date of Patent: June 4, 1991
    Assignee: Merck & Co., Inc.
    Inventors: David F. Sesin, Jerrold M. Liesch, Jimmy M. Fountoulakis, Prakash S. Masurekar, Louis Kaplan, Carol F. Wichmann